Globus Medical Q3 2021 revenue up 6.3% to $229.7M; GAAP EPS $0.45, non-GAAP $0.50; FY guidance reaffirmed

GLOBUS MEDICAL INC

2021-Q3 EPS reported $1.30 revenue$708,081,000

Worldwide net sales $229.7M (+6.3% YoY); US sales +8.8%, International -7.2%.
GAAP net income $47.2M (20.6% of sales); GAAP diluted EPS $0.45 vs $0.44; non-GAAP diluted EPS $0.50 vs $0.49.
Non-GAAP adjusted EBITDA $78.3M (34.1% of sales); operating cash flow $77.3M; free cash flow $59.5M.
Cash, equivalents and marketable securities $985M; debt-free. FY2021 guidance reaffirmed: net sales $950M, non-GAAP diluted EPS $2.00.
CEO cites market share gains, Enabling Technology momentum, best recruiting quarter, and FDA clearances for Excelsius3D and ExcelsiusHUB.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.